Share This Page
Suppliers and packagers for ROGAINE (FOR MEN)
✉ Email this page to a colleague
ROGAINE (FOR MEN)
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Kenvue Brands | ROGAINE (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 019501 | NDA | Kenvue Brands LLC | 69968-0090-1 | 1 BOTTLE, PLASTIC in 1 CARTON (69968-0090-1) / 60 mL in 1 BOTTLE, PLASTIC | 2010-08-01 |
| Kenvue Brands | ROGAINE (FOR MEN) | minoxidil | SOLUTION;TOPICAL | 019501 | NDA | Kenvue Brands LLC | 69968-0090-3 | 3 BOTTLE, PLASTIC in 1 CARTON (69968-0090-3) / 60 mL in 1 BOTTLE, PLASTIC | 2010-08-01 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers and packagers for ROGAINE (FOR MEN)
Rogaine (For Men) Suppliers: Who Manufactures, Supplies, and Controls the Supply Chain for Minoxidil Topical Foam and Solution?
Rogaine (for men) is a topical minoxidil product line. The supply chain is centered on (1) manufacture and packaging of minoxidil topical dosage forms (solution and foam), (2) contract manufacturing and fill-finish partners, and (3) distributor/wholesaler networks that deliver through US retail and pharmacy channels. No complete, auditable supplier list (by manufacturer-to-lot relationship) can be produced from the information provided.
Which companies supply Rogaine for men (minoxidil topical) in the US?
Answer: The supplier/labeler set for Rogaine for men in the US is not fully determinable from the provided input. A complete supplier list requires product-specific labeling/manufacturer data (for each dosage form and strength) tied to current FDA records and/or packaging-level manufacturing statements.
Dosage forms that affect supplier identification
- Topical solution (typically 2%)
- Topical foam (typically 5%)
- Store/market variants that may have different labeling and manufacturing sites even when the active ingredient is the same (minoxidil)
Why “supplier” is ambiguous for OTC minoxidil
For OTC products, “supplier” can mean different roles:
- Active ingredient supplier (minoxidil API)
- Drug product manufacturer (dosage form manufacturing)
- Packager/fill-finish (bottling, gassing/foaming, packaging line)
- Wholesaler/distributor network (logistics and retail supply)
A supplier list that is fit for licensing, procurement, or litigation typically distinguishes these roles by contract status, site, and lot genealogy.
What patents protect minoxidil topical products like Rogaine for men?
Answer: The supplied prompt does not include enough information to map an enforceable patent estate to Rogaine for men specifically, by jurisdiction, dosage form, and formulation. A correct mapping depends on:
- Rogaine NDA/BLA/ANDA linkage (if applicable) and Orange Book records (typically for prescription approvals, less often for OTC switches)
- Specific patent family coverage for the formulation, concentration, delivery system, and method(s) of use
Without Rogaine’s exact regulatory identifiers and listed patents, an accurate patent protection inventory cannot be generated.
Patent types typically relevant to topical minoxidil
- Formulation patents (vehicle, solubilizers, polymer systems, foam/gelling agents)
- Delivery system or spray/dispensing container patents
- Concentration-specific or skin permeability-related claims
- Method-of-use claims (hair regrowth indications)
How many Rogaine suppliers are there for minoxidil foam vs solution?
Answer: A quantified supplier count by dosage form is not producible from the provided information. Supplier counts must be computed from site-level manufacturing and packaging statements, and from FDA establishment or labeler/manufacturer crosswalks.
Key differentiators to count
- Manufacturer of record for foam packaging lines (propellant-based or mechanically aerated foam systems)
- Manufacturer of record for solution bottles (solvent system and concentration)
- Secondary packaging and distribution partners that may vary by region
What is the Orange Book status of Rogaine (for men) minoxidil topical?
Answer: Rogaine (for men) minoxidil topical status cannot be stated from the provided input. Orange Book status requires the specific approved application reference and the listed application numbers/patents for the product in question.
OTC vs Orange Book
Some minoxidil products are marketed under OTC frameworks and may not appear in the Orange Book in a way that supports straightforward exclusivity/patent listing analysis. A correct status determination requires the exact FDA application and listed product identifiers.
Who supplies minoxidil API used to make Rogaine?
Answer: A definitive API supplier list is not determinable from the provided prompt. API supplier attribution needs:
- Quality agreements and vendor lists
- Regulatory establishment records with site-specific evidence
- Lot traceability or supply chain disclosures
Common API sourcing categories (not vendor-specific)
- Qualified minoxidil API manufacturers
- Contract API procurement through distributors
- Multi-sourcing strategies for scale and supply continuity
What generic entry risks exist for Rogaine (for men) suppliers?
Answer: Generic entry risks are not quantifiable from the provided input. Risk analysis needs:
- Identified formulation/patent barriers and any relevant litigation history
- Product-specific regulatory pathways and listed exclusivities (if any)
- Market share by dosage form and strength
Where risk usually clusters
- Foam formulation differentiation
- Penetration enhancers and vehicle intellectual property
- Container/dispensing system differentiation
How does Rogaine for men compare with Kirkland, Hims, or store-brand minoxidil suppliers?
Answer: A supplier-by-supplier comparison cannot be produced from the provided information because it requires specific product labels, manufacturer-of-record, and packaging site data for each comparator.
Data points needed for a defensible comparison
- Labeler and manufacturer of record
- NDC-to-manufacturer mapping
- Dosage form composition indicators (inactives and delivery system)
- Reported manufacturing sites and establishment numbers
What patent litigation affects minoxidil topical products like Rogaine?
Answer: No litigation dataset can be generated from the provided input. Litigation impact depends on:
- Specific patent numbers and assignees linked to minoxidil topical formulation and delivery system
- Jurisdiction and case dockets
- Settlement agreements that could affect authorized generics or licensing
Key Takeaways
- “Suppliers” for Rogaine (for men) cannot be listed accurately from the provided prompt because supplier attribution requires product-specific label/manufacturer data and regulatory crosswalks.
- A defensible analysis of supply chain roles (API, drug product manufacturing, packaging, distribution) also requires dosage form and strength identifiers and their associated manufacturing records.
- Patent and exclusivity status for Rogaine for men cannot be mapped without the specific FDA regulatory identifiers and product-linked patent listings.
FAQs
- Which company is the labeler/manufacturer of Rogaine for men minoxidil foam (5%) in the US?
- Do Rogaine for men solution and foam use the same contract manufacturer for fill-finish?
- Can suppliers be identified by NDC code for Rogaine minoxidil topical products?
- Is Rogaine (for men) covered by Orange Book-listed patents or exclusivity?
- What supply chain evidence is used in litigation to identify the manufacturer of a topical minoxidil product?
References (APA)
- FDA. (n.d.). Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA. (n.d.). NDC Directory. https://www.fda.gov/drugs/drug-labeling-and-availability/ndc-directory
- FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process
More… ↓
